| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| S9083 |
Global fee urgent care centers |
67,623 |
39,475 |
$3.22M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
52,297 |
45,935 |
$1.48M |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
14,284 |
12,839 |
$877K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
9,069 |
8,422 |
$446K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
1,633 |
1,533 |
$156K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
11,098 |
10,441 |
$59K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
2,623 |
2,276 |
$49K |
| 90473 |
|
3,385 |
3,013 |
$19K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,477 |
1,306 |
$7K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
855 |
816 |
$4K |
| 81025 |
|
1,515 |
1,416 |
$4K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
158 |
155 |
$3K |
| 81003 |
|
3,109 |
2,892 |
$3K |
| 81002 |
|
1,180 |
1,123 |
$870.62 |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
15 |
15 |
$844.71 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
18 |
18 |
$646.39 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
446 |
402 |
$352.75 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
111 |
105 |
$145.86 |
| 87807 |
|
17 |
16 |
$128.70 |
| H0033 |
Oral medication administration, direct observation |
91 |
85 |
$120.00 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
569 |
526 |
$116.69 |
| 81001 |
|
50 |
48 |
$82.46 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
28 |
25 |
$20.91 |
| A9150 |
Non-prescription drugs |
4,685 |
3,277 |
$4.35 |
| J8499 |
Prescription drug, oral, non chemotherapeutic, nos |
269 |
253 |
$0.07 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
164 |
153 |
$0.04 |
| 73610 |
|
15 |
12 |
$0.00 |
| A6448 |
Light compression bandage, elastic, knitted/woven, width less than three inches, per yard |
169 |
109 |
$0.00 |
| A4570 |
Splint |
15 |
15 |
$0.00 |
| 99000 |
|
20 |
19 |
$0.00 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
67 |
44 |
$0.00 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
26 |
12 |
$0.00 |